DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xxd4tr/regenerative) has announced the addition of the "Regenerative Medicine Partnering Terms and Agreements" report to their offering.
The Regenerative Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies.
Trends in regenerative medicine
Deal terms analysis
Partnering agreement structure
Partnering contract documents
Top deals by value
Most active dealmakers
Average deal terms for regenerative medicine and stem cells
The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine and stem cells partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors regenerative medicine and stem cells technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
This report provides details of the latest regenerative medicine and stem cells agreements including cell therapy agreements announced in the healthcare sector.
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in regenerative medicine dealmaking
Chapter 3 - Leading regenerative medicine deals
Chapter 4 - Big pharma regenerative medicine deals
Chapter 5 - Big biotech regenerative medicine deals
Chapter 6 - Regenerative medicine partnering contracts directory
Chapter 7 - Regenerative medicine dealmaking by technology type
For more information visit http://www.researchandmarkets.com/research/xxd4tr/regenerative
